CCT Research expands COVID-19 clinical trial capabilities to Salt Lake

CCT Research, a Mesa, Arizona-based provider of community-based, embedded clinical research that is currently supporting clinical trials for COVID-19 vaccines in partnership with multiple pharmaceutical companies, has expanded its clinical trial operations to the Salt Lake City area. CCT will partner with Olympus Family Medicine, Ogden Clinic and Springville Dermatology, increasing CCT’s total site network to 17 locations nationwide.

CCT offers a unique approach to clinical trials by embedding clinical research in physician practices and care communities, allowing patients to participate in studies without leaving the comfort of their community.

“Our goal is to provide clinical research opportunities to patients in a safe, trusting, local environment, and we’re thrilled to make this a reality in Utah,” said CJ Anderson, president of CCT. “Clinical research offers patients the opportunity to receive investigational treatments that may not otherwise be available. By making studies more convenient, we can improve participant engagement and data quality, enabling clinicians to deliver leading-edge patient care options.”

CCT said it is expanding its trials for COVID-19 vaccines to the Salt Lake City locations. In addition to COVID-19, CCT’s primary therapeutic areas are neurology, dermatology and family practice.

“We are excited to be part of the CCT family. Clinical research is a vital component of the healthcare landscape, and this important work allows physicians in the community to support critical advancements in medicine,” said Dr. John Hemmersmeier, a family medicine physician with the Ogden Clinic.